Trials for new Alzheimer's drugs have been failing a lot, lately. But it may be premature to abandon these drugs altogether.
Academic rigor, journalistic flair
Articles on beta amyloid plaques
Displaying all articles
A lot of Alzheimer's treatments focus on removing plaques in the brain. But could this be the wrong target?
The first clinical trial examining a drug to treat Alzheimer's was begun 30 years ago. There is still no cure and no known way to prevent the disease. Two factors may contribute to that.
Researchers have found evidence of the same brain pathologies in dolphins that are present in the brains of humans who died with Alzheimer's. What might this suggest about Alzheimer's in humans?
Top contributors
-
Postdoctoral Researcher in Neuroscience, University of Sussex
-
Director, Evelyn F. and William L. McKnight Brain Institute Director, 1Florida Alzheimer’s Disease Research Center, Professor, Department of Neuroscience, College of Medicine University of Florida, University of Florida
-
Assistant Scientist, University of Florida
-
Professor, Neuroscience, University of Florida
-
PhD Candidate, University of Sussex
-
Liverpool John Moores University
